IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Gilead Sciences, Inc.

Q1 2025 Holdings

Filed 2025-05-13 | 14 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcellx Inc(ACLX)COMMON STOCK03940C100$440.9M6,720,80337.3%
Galapagos NV(GLPG)SPON ADR36315X101$419.4M16,707,47735.5%
Arcus Biosciences Inc(RCUS)COM03969F109$246.7M31,424,76020.9%
Assembly Biosciences Inc(ASMB)COM NEW045396207$21.1M2,209,4711.8%
Merus N VCOMN5749R100$19.0M452,5271.6%
Kyverna Therapeutics Inc(KYTX)COM501976104$8.0M4,126,1190.7%
Tango Therapeutics Inc(TNGX)COM87583X109$6.7M4,854,4430.6%
Xilio Therapeutics Inc(XLO)COM98422T100$6.6M9,105,4510.6%
Kalaris Therapeutics Inc(KLRS)COM482929106$5.8M723,2730.5%
Hookipa Pharma Inc(HOOK)COM NEW43906K209$2.0M1,875,9450.2%
Allogene Therapeutics Inc(ALLO)COM019770106$1.7M1,156,6890.1%
Leap Therapeutics Inc(CYPH)COM NEW52187K200$1.6M5,319,1480.1%
Ikena Oncology IncCOM45175G108$1.5M1,159,1450.1%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$359.8K369,8550.0%